Bangladeshi company develops arsenicosis medicines
Unb, Dhaka
Viola Vitalis, a Bangladeshi company, has developed Arsenicure, an ointment for treatment of external symptoms, and Ars-detox, a capsule formulation to neutralise the accumulated arsenic inside the body.
The founder of Viola Vitalis, young scientist Dr Abdul Kader, made the announcement at a press conference held at the National Press Club yesterday morning.
Bangladesh Academy of Sciences and Viola Vitalis jointly organised the press conference.
Addressing the press conference, Dr Abdul Kader said there are certain specific problems, which are only encountered in developing countries but not experienced in the developed countries. In the developing countries, marginal people are mostly the victims of arsenicosis.
But, he said, the pharmaceutical or nutraceutical companies are not interested to develop products or services for the marginal people as their only “interest is on return on investment”.
Dr Kader said Viola Vitalis and Allium Vitals have developed an innovative system, which has been found effective to address arsenicosis problems.
He said that Viola Vitalis in cooperation with Helmholtz Centre for Environment Research, Leipzig, Germany are now developing ‘biosensor to detect specific arsenic contamination’ from water samples which will be user-friendly.
Dr Kader said: “The nutraceuticals are made based on natural preparations. It has been tested on animals. All ingredients are classified as GRAS by the FDA (Federal Drug Administration of United States Government). Generally, it is recognised as safe for human consumption.”
Secretary of Bangladesh Academy of Sciences and former chairman of Atomic Energy Commission Prof Naiyyum Chowdhury, scientist Prof Dr Amir H Khan and representative of the Helmholtz Centre for Environment Research Carola Endes also spoke at the press conference.
No comments:
Post a Comment